IL‐8 is also a recognized proinflammatory cytokine and is reported to have a high concentration in patients with inflammatory bowel disease (IBD); however, to date, its effect on CYP expression and/or activity is still unclear.1, 5, 6. Here, CXCL8 is linked to inflammatory bowel disease.